Gird criteria for fat embolism
Gurd criteria fat embolism syndrome diagnosis major minor criteria
| Feature | Details |
|---|---|
| Petechial rash | Non-blanching petechiae typically on upper chest, axillae, subconjunctiva, oral mucosa |
| Respiratory insufficiency / hypoxemia | Progressive hypoxemia and respiratory distress, 12-72 hrs post-injury |
| Cerebral involvement | Altered consciousness, confusion, drowsiness, not attributable to other causes (disproportionate to hypoxia) |
| Pulmonary edema | (listed separately in some classifications) |
| Feature | Details |
|---|---|
| Tachycardia | HR >110-120 bpm |
| Fever | Temperature >38.5°C |
| Retinal changes | Fat emboli or petechiae on fundoscopy |
| Jaundice | Unexplained |
| Renal signs | Oliguria, anuria, or lipiduria/hematuria |
| Fat globules in sputum or urine |
| Feature | Details |
|---|---|
| Fat macroglobulinemia | Fat globules in blood, urine, sputum, BAL, or CSF - required for diagnosis in original Gurd criteria |
| Thrombocytopenia | Platelet count <150,000/mm³ |
| Unexplained anemia | Acute drop in hemoglobin |
| Elevated ESR | High erythrocyte sedimentation rate |
| System | Scoring |
|---|---|
| Schonfeld Criteria | Weighted point system: Petechial rash = 5 pts, Diffuse infiltrates on X-ray = 4 pts, Hypoxemia = 3 pts, Fever/tachycardia/confusion = 1 pt each; Score >5 = FES |
| Lindeque Criteria | Based on respiratory parameters alone (pO2 <60 mmHg + at least one other respiratory criterion) |
Feda for fat embolism
Feda criteria fat embolism syndrome diagnosis
"FEDA" OR "Feda score" fat embolism mnemonic orthopedics
| Letter | Feature |
|---|---|
| F | Fever |
| E | Embolism (respiratory - hypoxemia) |
| D | Drowsiness / altered consciousness (neurological) |
| A | Axillary petechiae (rash) |
| Criteria | Key Points |
|---|---|
| Gurd & Wilson | 1 major + 4 minor; or 2 major criteria |
| Schonfeld | Weighted score >5 (petechiae = 5, X-ray infiltrates = 4, hypoxemia = 3, fever/tachycardia/confusion = 1 each) |
| Lindeque | Respiratory parameters alone (PaO2 <60 mmHg + ≥1 other respiratory criterion) |
Management of fat embolism
fat embolism syndrome management treatment guidelines 2024
Core principle: Treatment is supportive. No specific pharmacological cure exists.
| Severity | Intervention |
|---|---|
| Mild hypoxia | Supplemental O2 (maintain SpO2 >90%, PaO2 >60 mmHg) |
| Moderate | Non-invasive ventilation / CPAP |
| Severe (ARDS) | Intubation + mechanical ventilation with lung-protective strategy |
| Agent | Evidence |
|---|---|
| Corticosteroids (therapeutic) | Meta-analysis shows reduced mortality - still controversial; not standard of care |
| Heparin | Promoted lipolysis in animal models; risk of bleeding outweighs benefit - not recommended |
| Dextran | Reduces free fatty acid mobilization in theory - no proven clinical benefit |
| Ethanol | Inhibits lipolysis - no proven clinical benefit, now abandoned |
| Albumin | May bind free fatty acids; used as supportive therapy when hypoalbuminaemia present |
Suspected FES (trauma + classic triad)
↓
ABC stabilization
↓
Oxygen / Ventilatory support (cornerstone)
↓
Early fracture fixation (within 24h)
↓
Hemodynamic support (fluids ± vasopressors)
↓
Treat complications: ARDS, RV failure, cerebral edema
↓
Consider methylprednisolone (controversial)